Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil for Preservation of Beta Cell Function in Children with Type 1 Diabetes
NCT07199946Phase 2Recruiting
- Sponsor
- Diamyd Medical
- Start
- Aug 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verapamil in type 1 diabetes mellitus (T1D), sponsored by Diamyd Medical. Started Aug 2025; status: recruiting.
02
Drugs
verapamil
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07199946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07199946.